DiaMedica Therapeutics Price Fair Value Over Time
| DMAC Stock | USD 5.21 0.13 2.56% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out DiaMedica Therapeutics Performance and DiaMedica Therapeutics Correlation. DiaMedica |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.56) | Return On Assets (0.24) | Return On Equity (0.35) |
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price Fair Value Analysis
Compare DiaMedica Therapeutics and related stocks such as Milestone Pharmaceuticals, Seres Therapeutics, and Inhibikase Therapeutics Price Fair Value Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIST | (10.9745) | (10.9745) | (10.9745) | (10.9745) | (10.9745) | (10.9745) | (10.9745) | (10.9745) | (6.5833) | 2.1991 | 1.3738 | 2.4335 | 2.5337 | 4.2774 | 4.49 |
| MCRB | 167 | 167 | 167 | (138) | (57.2837) | 4.0203 | 2.9743 | 6.7572 | (3.8331) | (4.0444) | 11.1865 | 5.8087 | 56.1283 | (3.9951) | (3.8) |
| IKT | (57.1071) | (57.1071) | (57.1071) | (57.1071) | (57.1071) | (57.1071) | (57.1071) | (70.9062) | (102) | (22.7563) | 7.0879 | 0.6968 | 0.5993 | 0.617 | 0.65 |
| ONCY | 6.3026 | 9.5659 | 20.0696 | 6.2011 | 3.9176 | 1.7072 | 3.1719 | 11.26 | 6.3853 | (1.3 K) | 4.9475 | 2.6047 | 4.8331 | 4.2876 | 4.5 |
| SCPH | (8.659) | (8.659) | (8.659) | (8.659) | (8.659) | (8.659) | (4.2601) | 0.3379 | (0.7233) | (0.8133) | (0.8039) | (0.7238) | (0.8976) | 6.4883 | 6.81 |
| LYRA | (1.0862) | (1.0862) | (1.0862) | (1.0862) | (1.0862) | (1.0862) | (1.0862) | (1.0862) | (1.0862) | 32.7347 | 1.3146 | 1.6499 | 1.1757 | 2.9185 | 2.77 |
| CNTA | (138) | (138) | (138) | (138) | (138) | (138) | (138) | (138) | (138) | (138) | (138) | 2.0614 | 0.8613 | 3.2406 | 3.4 |
| IOVA | 58.5 K | (5.9404) | (1.552) | 5.823 | 4.3849 | 3.2959 | 2.3012 | 3.5877 | 1.8467 | 11.5116 | 9.7748 | 4.7108 | 2.0368 | 3.2699 | 3.11 |
| XFOR | (2.2761) | (2.2761) | (2.2761) | (2.2761) | (2.2761) | (2.2761) | (1.3811) | 0.4481 | 0.2958 | 0.9547 | 1.7733 | 0.9154 | 0.8519 | 2.9178 | 3.06 |
| TERN | 6.1033 | 6.1033 | 6.1033 | 6.1033 | 6.1033 | 6.1033 | 6.1033 | 6.1033 | 6.1033 | 110 | 6.7362 | 1.1145 | 1.3245 | 1.811 | 1.72 |
| DAWN | (136) | (136) | (136) | (136) | (136) | (136) | (136) | (136) | (136) | (136) | (26.8486) | (8.1883) | (5.2244) | 3.3609 | 3.53 |
| HOOK | (53.5765) | (53.5765) | (53.5765) | (53.5765) | (53.5765) | (53.5765) | (53.5765) | (53.5765) | 51.4733 | 18.5266 | 1.8528 | 0.8556 | 0.5181 | 0.8521 | 0.81 |
DiaMedica Therapeutics and related stocks such as Milestone Pharmaceuticals, Seres Therapeutics, and Inhibikase Therapeutics Price Fair Value description
My Equities
My Current Equities and Potential Positions
| DiaMedica Therapeutics | DMAC |
| Classification | Pharmaceutical Products |
| Location | Minnesota; U.S.A |
| Exchange | NASDAQ Exchange |
USD 5.21
Check out DiaMedica Therapeutics Performance and DiaMedica Therapeutics Correlation. For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.